Your session is about to expire
← Back to Search
Digital Health Tech + Behavioral Therapy for Eating Disorders
Study Summary
This trial is testing how well two types of self-monitoring (tracking what you eat and how you feel) and two types of micro-interventions (daily reminders and weekly check-ins) work when combined with standard cognitive behavioral therapy for bulimia nervosa and binge eating disorder.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I need urgent care for health issues caused by my eating disorder.
- Group 1: Base BT + Skills Monitoring On + Automated Reminder Messages
- Group 2: Base BT (Skills Monitoring Off + No Micro-Interventions)
- Group 3: Base BT + Skills Monitoring On + No Micro-Interventions
- Group 4: Base BT + Skills Monitoring On + JITAIs
- Group 5: Base BT + Skills Monitoring Off + Automated Reminder Messages
- Group 6: Base BT + Skills Monitoring Off + JITAIs
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this trial actively seeking participants at the moment?
"According to the data posted on clinicaltrials.gov, this medical trial has already ceased enrollment of new patients. It was initially published on December 1st 2022 and last modified on July 21st 2022; however, there are currently 106 other studies that remain open for recruitment."
Can persons aged 65 and above participate in the experiment?
"This study is taking applications from adults aged 18 to 70."
Am I eligible to partake in this experiment?
"This research is actively searching for 264 individuals aged 18-70 suffering from bulimia nervosa. Qualifying patients must have experienced at least 12 uncontrolled episodes in the past 3 months, have a BMI of 18.5 or higher, be legally able to partake in assessments and treatment within the United Sates and sign informed consent forms."
What is the expected outcome of this investigation?
"This medical trial sets out to measure participants' BMI over a time frame of 16 weeks, followed by 6 and 12-month post-treatment assessments. Secondary outcomes include changes in impulsivity (as measured via the UPPS-P Impulsive Behaviors Scale), acceptability/feasibility (measured through TAM scales and a feedback questionnaire) as well as frequency/success rate of skill use related to emotional regulation."
Share this study with friends
Copy Link
Messenger